BR112012011224A2 - theobromine and agent combined with an antitussive opioid and its therapeutic use - Google Patents

theobromine and agent combined with an antitussive opioid and its therapeutic use

Info

Publication number
BR112012011224A2
BR112012011224A2 BR112012011224A BR112012011224A BR112012011224A2 BR 112012011224 A2 BR112012011224 A2 BR 112012011224A2 BR 112012011224 A BR112012011224 A BR 112012011224A BR 112012011224 A BR112012011224 A BR 112012011224A BR 112012011224 A2 BR112012011224 A2 BR 112012011224A2
Authority
BR
Brazil
Prior art keywords
theobromine
opioid
antitussive
therapeutic use
agent combined
Prior art date
Application number
BR112012011224A
Other languages
Portuguese (pt)
Inventor
Robin Mark Bannister
John Brew
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of BR112012011224A2 publication Critical patent/BR112012011224A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

teobromina e agente combinado com um opióide antitussígeno e seu uso terapêutico. um agente que compreende teobromina e um opióide antisussígeno, para um simultâneo, sequencial ou separado, em terapias. preferivelmente em terapias da tosse.theobromine and agent combined with an antitussive opioid and its therapeutic use. an agent comprising theobromine and an antisussive opioid for simultaneous, sequential or separate in therapies. preferably in cough therapies.

BR112012011224A 2009-11-13 2010-11-12 theobromine and agent combined with an antitussive opioid and its therapeutic use BR112012011224A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0919893.8A GB0919893D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy
PCT/GB2010/051896 WO2011058374A1 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy

Publications (1)

Publication Number Publication Date
BR112012011224A2 true BR112012011224A2 (en) 2017-03-01

Family

ID=41509327

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012011224A BR112012011224A2 (en) 2009-11-13 2010-11-12 theobromine and agent combined with an antitussive opioid and its therapeutic use

Country Status (18)

Country Link
EP (1) EP2498776A1 (en)
JP (2) JP2013510842A (en)
CN (1) CN102740853B (en)
AU (1) AU2010317668C1 (en)
BR (1) BR112012011224A2 (en)
CA (1) CA2780704C (en)
CO (1) CO6551745A2 (en)
EC (2) ECSP12011893A (en)
GB (1) GB0919893D0 (en)
IL (1) IL219769A0 (en)
MX (1) MX2012005538A (en)
NZ (1) NZ599957A (en)
PE (1) PE20121472A1 (en)
RU (1) RU2587329C2 (en)
SG (1) SG10201407496SA (en)
UA (1) UA105940C2 (en)
WO (1) WO2011058374A1 (en)
ZA (1) ZA201204247B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3850568D1 (en) * 1987-10-08 1994-08-11 Andor Bilas FABRIC MIXTURE TO STABILIZE THE METABOLISM LOCATION.
BR9407414A (en) * 1993-09-07 1996-11-12 Procter & Gamble Compositions containing a non-steroidal propionic acid anti-inflammatory agent amino acid salt and at least one decongestant an expectorant an antihistamine and an antitussive
HUP9700654A2 (en) 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
US6608073B1 (en) * 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
US8080554B2 (en) * 2001-12-12 2011-12-20 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
EP1603533B1 (en) * 2003-02-28 2009-04-15 YM Biosciences Inc. Opioid delivery system
CN1593451A (en) * 2003-09-12 2005-03-16 杨喜鸿 Externally applied medicine for promoting male erection
EP1844792A4 (en) * 2004-12-14 2008-05-21 Shionogi & Co Therapeutic agent for constipation
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (en) * 2006-07-25 2008-01-30 안국약품 주식회사 Compositions for treating of cough

Also Published As

Publication number Publication date
GB0919893D0 (en) 2009-12-30
JP2013510842A (en) 2013-03-28
WO2011058374A1 (en) 2011-05-19
RU2587329C2 (en) 2016-06-20
UA105940C2 (en) 2014-07-10
JP2016041748A (en) 2016-03-31
EP2498776A1 (en) 2012-09-19
AU2010317668A1 (en) 2012-06-07
AU2010317668B2 (en) 2015-01-22
AU2010317668C1 (en) 2016-02-11
SG10201407496SA (en) 2015-02-27
ECSP12011893A (en) 2012-10-30
CA2780704C (en) 2018-07-17
ECSP12011892A (en) 2012-09-28
CA2780704A1 (en) 2011-05-19
NZ599957A (en) 2014-05-30
RU2012124063A (en) 2013-12-20
IL219769A0 (en) 2012-07-31
PE20121472A1 (en) 2012-11-30
ZA201204247B (en) 2013-02-27
CO6551745A2 (en) 2012-10-31
CN102740853B (en) 2015-04-08
CN102740853A (en) 2012-10-17
MX2012005538A (en) 2012-09-28

Similar Documents

Publication Publication Date Title
BR112012014159A8 (en) therapeutic combinations of theobromine and an antihistamine
BR112012011227A2 (en) theobromine and agent combined with another non-opioid antitussive and its therapeutic use
BRPI0714712B8 (en) drug delivery device
GT201300320A (en) COMBINATION THERAPY INCLUDING A CDK4 / 6 INHIBITOR AND A PI3K INHIBITOR FOR USE IN CANCER TREATMENT.
CL2007000876A1 (en) USE OF AN ANTAGONIST OF THE VASCULAR ENDOTELIAL GROWTH FACTOR (VEGF) IN COMBINATION WITH A SECOND AGENT UNDERSTANDING A MIELOID CELL REDUCING AGENT TO TREAT A RESISTANT TUMOR IN A SUBJECT; AND TUMOR DIAGNOSIS METHOD.
MX2009010066A (en) Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer.
CL2008002381A1 (en) Immunostimulatory oligonucleotide; pharmaceutical composition comprising it; and its use to treat a disorder or condition in a subject, including cancer.
MX2013004123A (en) Antitussive compositions comprising memantine.
PA8631801A1 (en) TREATMENT OF DISRUPTION HEMORRAGY IN EXTENDED ANTI-CONCEPTIVE REGIMES
BR112012011224A2 (en) theobromine and agent combined with an antitussive opioid and its therapeutic use
TW200744568A (en) Epinephrine dosing regimens
MX343598B (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy.
CL2013001324A1 (en) Kit comprising ec145 and one or more additional chemotherapeutic agents; Use to treat cancer.
BR112012022243A8 (en) Use of a thioxanthone-based autophagy inhibitor and an autophagy-inducing compound for cancer therapy, pharmaceutical composition and pharmaceutical kit
BR112013017953A2 (en) PHARMACEUTICAL COMPOSITION, TOPICAL FORMULATION, METHOD, AND PHOTOSENSITIZING COMPOSITION
AR077659A1 (en) ABSORBENT NUCLEUS AND ABSORBENT ARTICLE
BR112015019021A2 (en) method and system for generating a configuration output
ECSP12012132A (en) COMBINATION OF THEOBROMINE WITH A DESCONGESTIVE AND ITS USE FOR THE TOS TREATMENT
DK2050435T3 (en) cough Preparation
CL2010001594A1 (en) Use of nifurtimox to prepare a medicine useful in the treatment of diseases caused by trichomonadide.
BR112014030570A2 (en) wild thyme extracts and use of these
CL2011000252A1 (en) Use of estriol to prepare a useful medication in the prevention and / or treatment of urogenital atrophy in women.
ECSP12011969A (en) THERAPEUTIC COMBINATIONS OF THEOBROMINE AND AN ANTIHISTAMINE
杨帆 An Analysis of Context of Situation in Public Speaking
廖勇 Syntactic Structure of Interrogative Sentences and Relative Clauses in English--An over-view of Wh-movement

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2493 DE 16/10/2018.